What Rilas Technologies does

Rilas Technologies is a contract analytical chemistry and purification CRO founded in 2009 by Laszlo Varady, PhD and operating from a single laboratory facility at 400 West Cummings Park, Suite 5000 in Woburn, Massachusetts. The company provides chromatography-based analytical and purification services to biotech customers spanning early discovery through late-stage pre-clinical development, with explicit coverage across small molecules, peptides, proteins, antibodies, ADCs, oligonucleotides, and DNA-encoded libraries. Customers are organized across three primary horizontal segments: early-stage biotech startups (accessed through the in-house incubator and LabCentral sponsorship), mid-stage growing biotechs requiring scalable purification workflows, and multinational pharmaceutical organizations with complex impurity profiling and regulatory documentation requirements.

The company's technology platform is built around Agilent chromatography instrumentation, including Agilent 1290 Infinity II mass-directed preparative HPLC, Agilent 1260 Infinity II Bio-inert HPLC for biomolecules, Agilent 1260 Infinity II SFC/MS for chiral work, and Agilent 6545XT AdvanceBio LC/Q-TOF for high-resolution mass spectrometry. In May 2023, Rilas integrated MOBILion Systems' MOBIE High-Resolution Ion Mobility (HRIM) platform with its Q-TOF to extend capabilities for difficult chiral, enantiomeric, and biomolecule separations. Proprietary methodology branded as the "Rilas Platform" claims a 95%+ success rate across analytical and purification processes, and the firm also offers an in-house EPSA (Experimental Polar Surface Area) SFC-based physico-chemical measurement for permeability profiling. Reported throughput capacity is hundreds of purifications per week, with a five-business-day standard turnaround for 24-sample library purification and chiral separations under 5 grams.

Rilas operates a multi-stream revenue model combining fee-for-service analytical and purification work on per-compound or per-sample pricing with no minimum orders, FTE-based on-site scientist placements under the Rilas In Sourcing subscription model (typically multi-year), short-duration Rilas Consulting engagements for laboratory setup and method development, and managed incubator space (3,000 sq ft shared lab plus 1,500 sq ft office) offering preferential pricing on Rilas services to resident startups. Go-to-market is sales-led, leveraging direct quote requests, conference participation (e.g., Boulder Peptide Symposium), technical content marketing via blog and monthly newsletters, an active LinkedIn presence, and ecosystem partnerships. The company is privately held and family-run, with no disclosed institutional funding, and is led by founder Laszlo Varady as President and CEO alongside VP of Business Development Gordon Carlson (former LabCentral, Waters, Biotage) and Director of Communications Julia Giessen.

Name

Rilas Technologies

Legal name

Rilas Technologies, Inc.

Website

https://rilastech.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Rilas Technologies is a Woburn, MA-based contract analytical chemistry and purification CRO serving biotech startups through multinational pharma with chromatography-based services across small molecules, peptides, proteins, antibodies, and oligonucleotides.

Ownership category

akta.pro rank

Product category

Contract Analytical Chemistry & Purification CRO Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industry

Functional Service Providers (FSP) & Resourcing CROs (HLAGAAAM)

Keywords

• Analytical chemistry services
• Compound purification services
• Chromatography CRO
• Biomolecule characterization
• Chiral separations

Headquarters

HQ city

Woburn

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Analytical Chemistry Services: Fee-for-service laboratory analysis including LC-MS QC, high-throughput HPLC analysis, physico-chemical measurements (solubility, stability, logD), and EPSA determinations. Revenue generated per compound or per sample with no minimum order requirements.
2. Purification Services: Preparative purification services for small molecules, peptides, proteins, antibodies, oligonucleotides, and chiral separations at scales from mg to multi-gram. Pricing based on scale and complexity.
3. Rilas In Sourcing: Placement of expert employee chemists in customer laboratories on FTE basis. Provides immediate productivity with experienced purification scientists working alongside customer scientists.
4. Rilas Consulting: Laboratory consulting services for lab setup, instrument selection, method development, and best practices. Typically one to several days of engagement.
5. Incubator Space: Managed lab and office space for biotech startups with preferential pricing on Rilas services. Includes 3,000 sq ft shared lab space and 1,500 sq ft office space.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Rilas Technologies is a contract analytical chemistry and purification services provider (CRO) that delivers HPLC, UPLC, SFC, and LC-MS/MS-based analytical and preparative purification services for biotech companies. Core offerings span small molecules, peptides, proteins, antibodies/ADCs, and oligonucleotides, including chiral separations, library purification, mass-directed preparative chromatography, and physico-chemical measurements such as solubility, stability, logD, and EPSA. Beyond fee-for-service laboratory work, the company offers Rilas In-Sourcing (placement of Rilas chemists at customer laboratories on an FTE basis), Rilas Consulting (lab setup and method development advisory), and Rilas Incubator (shared lab and office space with preferential pricing on Rilas services for biotech startups).

Product overview

Rilas Technologies is a contract analytical chemistry and purification CRO providing biotech companies with specialized laboratory services spanning small molecules, peptides, proteins, antibodies, and oligonucleotides. The core offerings are organized as three interconnected service suites: Purification Services (library purifications, small molecule, peptide, protein, antibody/ADC, and DEL purifications), Analytical Services (small molecule, peptide, protein, oligonucleotide, and antibody analyses, plus QC tests), and Chiral Services (chiral separations, chiral analysis, and EPSA measurements). PhysChem Measurements (solubility, stability, logD, glutathione reactivity) complement the analytical offerings. The company also offers three distinct service delivery models: Rilas In Sourcing (on-site chemist placement), Rilas Consulting (laboratory setup and method development), and the Rilas Incubator (shared lab space for startups). Instrumentation includes Agilent Q-TOF, HPLC, and SFC systems, plus ion mobility capabilities through the MOBILion partnership. Founded in 2009 and headquartered in Woburn, MA.

Differentiator

Problem solved

Functional benefit

Brands

• Rilas In Sourcing: Provides expert employee chemists who work in customer labs to increase productivity and shorten lead optimization cycle time
• Rilas Consulting
• Rilas Incubator

Products and services

• Library Purifications
• Small Molecule Purifications
• Peptide Purifications
• Protein Purifications
• Antibody/ADC Purifications
• DNA Encoded Library (DEL) Purifications
• Small Molecule Analyses
• Peptide Analyses
• Protein Analyses
• Oligonucleotide Analyses
• Antibody/ADC Analyses
• QC Tests
• Chiral Separations
• Chiral Analysis
• EPSA (Experimental Polar Surface Area) Measurements
• PhysChem Measurements
• Rilas In Sourcing
• Rilas Consulting
• Rilas Incubator

Quantifiable outcome

• 95%+ success rate in analytical and purification processes
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• MOBILion SystemscoreTechnology or Integration · 4 May 2023Strategic partnership integrating MOBIE High Resolution Ion Mobility (HRIM) Platform with Rilas' Agilent 6545XT Q-TOF instrument. Enables new separation capabilities for difficult enantiomeric and chiral separations of biologically active compounds including small molecules, peptides, oligos, antibodies, glycans, and more. Expands Rilas' analytical offerings with unprecedented characterization capabilities.
• Northeastern University (Pollastri Lab)minorStrategic or Co-development PartnerAcademic collaboration with Northeastern University's Pollastri Lab for research and development in analytical chemistry and purification methods.
• LabCentralcoreGTM or Marketing PartnerGeneral sponsorship of LabCentral, premier biotech incubator in Kendall Square, Cambridge, MA. Provides analytical expertise consultation to resident companies, enables data ownership for startups, and accelerates timelines for biotech innovation. Strategic partnership for accessing startup ecosystem.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/rilas-technologies-inc-
• Xx.com/rilastech

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rilas Technologies